55KRC: UP-NEXT study tests ovarian cancer treatment
April 13, 2023
The University of Cincinnati's Amanda Jackson joined 55KRC's Simply Medicine program to discuss the UP-NEXT ovarian cancer clinical trial.
April 13, 2023
The University of Cincinnati's Amanda Jackson joined 55KRC's Simply Medicine program to discuss the UP-NEXT ovarian cancer clinical trial.
March 29, 2023
Neurology Advisor highlighted research from the University of Cincinnati that found rates of infective endocarditis-related stroke in the United States increased with affected patients more likely to be intravenous drug users.
March 28, 2023
Treatment of the first patient in a clinical trial of FLASH proton therapy for cancers in the bones of the chest has been completed at the Cincinnati Children’s/University of Cincinnati Medical Center Proton Therapy Center.
April 18, 2023
Jacksonville, Florida television news station WJXT highlighted the VERIFY study being led by University of Cincinnati researchers that will examine if certain biomarkers can predict the likelihood that a patient will recover motor functions following a stroke.
April 28, 2023
The University of Cincinnati's Christopher T. Richards, MD, was a recent guest on the Know Stroke Podcast to discuss mobile stroke units and where research is headed to improve care.
February 3, 2023
The University of Cincinnati's Jeffrey Strawn and Jeffrey Mills and Cincinnati Children's Hospital Medical Center's Angela Scott joined WVXU's Cincinnati Edition to discuss a recent study examining hesitancy to treat childhood anxiety with medication.
January 3, 2023
The University of Cincinnati's LaTrice Montgomery was featured in a recent WHAS news report on Kentucky's new medical marijuana executive order.
February 8, 2023
Local 12 highlighted the University of Cincinnati's Andrew Waters and his research into novel treatments for pancreatic cancer.
September 9, 2022
UC postdoctoral researcher Nese Devenot talks to Wired magazine about challenges facing psychedelic therapies.
August 16, 2022
Psychedelics such as LSD, psilocybin and MDMA are gaining increasing attention in scientific and medical circles because of the potential they hold for treating anxiety disorders and emotional trauma. UC's Nese Devenot explains why psychedelics are seeing a research renaissance.